The market for in vivo imaging systems was valued at USD 114.66 million in 2022 and is anticipated to grow at a CAGR of 3.2% to reach USD 154.83 million by 2032.
| Report Attribute | Details |
|---|---|
| In Vivo Imaging Systems Market Value (2022) | USD 53.31 Million |
| In Vivo Imaging Systems Market Anticipated Value (2032) | USD 154.83 Million |
| In Vivo Imaging Systems Market Growth Rate (2022 to 2032) | 3.2% CAGR |
One of the key factors anticipated to accelerate the growth and demand of the in-vivo imaging systems market is the quickening pace of technical development in the field of molecular imaging. Over the course of the forecast period, it is also anticipated that an increase in the number of public-private partnerships and substantial financing for preclinical research would help to the expansion of the global market.
Additionally, the market's expansion is projected to be aided by the quickening development of healthcare services and technology as well as the quickening rise in demand for non-invasive small-animal imaging techniques. Furthermore, one of the important factors anticipated to propel the growth of the in vivo imaging systems market is the rise in knowledge regarding the advantages of early illness detection and the rate of acceptance of multi-modality imaging systems in clinical settings.
In vivo imaging system can be broken down into in vivo which means performed in living organism and imaging systems which means visual representation system. In other words it can be defined as the technique used for biological imaging in order to study the cellular activity and the effects of drugs in various diseases. It can be subdivided into morphological imaging systems and molecular imaging systems.
High-frequency micro-ultrasound, computed tomography (CT) scan and magnetic resonance imaging (MRI) constitute to morphological imaging systems whereas fluorescence, bioluminescence, single photon emission computed tomography (SPECT) and positron emission tomography (PET) constitute to Molecular Imaging systems.
In vivo Imaging systems can be used for both animals and Humans depending upon the purpose of use. Usually in vivo imaging systems are used in research laboratories to study the activity of a drug on the animals like albino mice albino rats etc. These small animal imaging consist of full body scan and targeted scan. Full body scan is popularly followed imaging method as it is economic and hence can be used for commercialization and regular validation of new drugs.
Small animal In vivo imaging includes the measurement and classification of molecular level biological process that are used to study the specific targeted drugs. Small animal In vivo imaging consist of micro MRI, micro CT, micro PET, micro SPECT, digital angiography, x-ray imaging and magnetic particle imaging.
Human In vivo Imaging systems are used to study the deformity or the disorder caused to the humans that may be disease induced, congenital or trauma induced. The imaging systems used here are similar to that in animals like CT Scan, PET scan, SPECT scan, MRI scan etc.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The main factors influencing In Vivo Imaging System include increasing customer demand for the product, successful marketing strategies in new markets, and large financial investments in product development.
One of the problems facing in vivo imaging systems on the market is their easy accessibility to competitors. The low price of alternatives is another hindrance in the industry. However, businesses plan to get over this problem by utilising cutting-edge technology and controlling prices, which will ultimately increase product demand.
Furthermore, researchers have identified significant obstacles for market participants that must be overcome for them to mitigate risks, modify their plans, and continue operations. Producers will be able to effectively manage their resources in this way without compromising the quality of their products or the timeliness of their market supply.
Principal Consultant
Businesses that make the right preparations can profit from them. The opportunities discussed in the report help the stakeholders and report buyers plan their investments effectively and get the best return on their money.
A few developments in the industry help organisations create more effective strategies. Current trends are covered in the study using the most recent data. Customers can learn about the new products on the market, and businesses can use this information to plan on developing significantly better solutions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Technological advancement of imaging systems, rise in the rate of adoption of multi-modality imaging systems in clinical and preclinical research studies, growth in the acceptance of preclinical imaging for drug discovery and development process, growing awareness about the benefits of early disease diagnosis are some of the crucial parameters driving the current Imaging markets.
A number of factors such as high implementation cost of sophisticated clinical and preclinical imaging systems, High cost of maintenance, low life span of accessories used are restricting the growth of the global imaging market.
The in vivo market has some well establish technology, but on and off there are some of the technological advancement taking place in the market. In case of MRI the currently used technology for diagnostic purpose ranges from 1.5 T to 3 T, for human clinical studies 9.4 T and animal clinical studies 21. T.
The combination of PET-MRI at 9.4 T is operational since 2009, but presently only brain can be imaged such high magnetic field strengths.
North America market is a leader for In vivo imaging systems followed by the European market. Research Institutes and Pharmaceutical companies, growing usage for in vivo imaging system and technological advancements, rising awareness and applications of functional imaging that are factors driving market growth.
Asia-Pacific market is also growing at fastest pace due to growing number of research institutes, increasing number of funds given by government for research and rising industry-academia partnerships for small animal research and increasing medical tourism.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The key players in the in vivo imaging system market include Bruker Corporation, Life Technologies Corporation, Miltenyi Viotech GmbH, Biosacan, Inc., Gamma Meddica, Targeson, Inc., Sanco Medical, Aspect Imaging, Mediso Medical Imaging Systems, Perkin Elmer, Inc., FUJIFILM Holdings Corporation and Siemens AG.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. In Vivo Imaging Systems Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global In Vivo Imaging Systems Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global In Vivo Imaging Systems Market Analysis and Forecast 6.1. Application 6.2. Technology 6.3. End-Use 7. Global In Vivo Imaging Systems Market Analysis and Forecast, By Application 7.1. Monitoring Drug Treatment Response 7.2. Bio Distribution Studies 7.3. Cancer Cell Detection 7.4. Biomarkers 7.5. Longitudinal Studies 7.6. Epigenetics 8. Global In Vivo Imaging Systems Market Analysis and Forecast, By Technology 8.1. Magnetic Resonance Imaging (MRI) 8.2. Digital Angiography 8.3. Ultrasound 8.4. Nuclear Imaging 8.5. Positron Emission Tomography (PET) 8.6. Single Photon Emission Computerized Tomography (SPECT) 8.7. Optical Imaging (OI) 8.8. Bioluminescence Imaging 8.9. Cerenkov Luminescence Imaging 8.10. Others 8.11. Ultrasound Imaging 8.12. Computerized Tomography (CT) 9. Global In Vivo Imaging Systems Market Analysis and Forecast, By End-Use 9.1. Hospitals 9.2. Clinics 9.3. Pharmaceutical Research Institutes 9.4. Diagnostic Laboratories 9.5. Forensic Laboratories 9.6. Educational Research Institutes 10. Global In Vivo Imaging Systems Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. Asia Pacific 10.6. Japan 10.7. Middle East and Africa 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 15. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 16. Japan Sales Analysis and Forecast, by Key Segments and Countries 17. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Application, Technology, and End-Use for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Bruker Corporation 20.2. Life Technologies Corporation 20.3. Miltenyi Viotech GmbH 20.4. Biosacan, Inc. 20.5. Gamma Meddica 20.6. Targeson, Inc. 20.7. Sanco Medical 20.8. Aspect Imaging 20.9. Mediso Medical Imaging Systems 20.10. Perkin Elmer Inc. 20.11. FUJIFILM Holdings Corporation 20.12. Siemens AG
Explore Healthcare Insights
View Reports
In Vivo Imaging Systems Market
